This research is Trending!
July 11, 2026European Heart Journal
Influenza vaccination, incident atrial fibrillation, and cardiovascular outcomes
Key result
Influenza vaccination linked to a ~20% lower risk of incident AF versus no vaccination.
- HR 0.80
- 95% CI 0.76-0.84
- P<0.0001
- n=276,888
Why the study?
Influenza triggers cardiovascular events and vaccination provides cardiovascular benefit, but its role in preventing incident AF and cardiovascular outcomes in clinical practice remains uncertain.
Does influenza vaccination reduce incident atrial fibrillation and cardiovascular outcomes in adults?
Study Design
Type
Cohort (n=276,888)
Multicenter
Yes
Structured PICO
Does influenza vaccination reduce incident atrial fibrillation and cardiovascular outcomes in adults?
P
Population
276,888 adults with a routine healthcare visit in 2022, propensity-score matched and followed for a mean of 2.7 years to evaluate the association of influenza vaccination with cardiovascular outcomes.
E
Exposure
Influenza vaccination within the preceding year
C
Comparator
No recorded influenza vaccination
O
Outcome
Incident atrial fibrillationhard clinical
Main Result
Hazard Ratio: 0.8 (95% CI 0.76–0.84)
Absolute Event Rate: 0.9% vs 1.1%
p-value: p=<0.0001
In a large real-world cohort, influenza vaccination was associated with a 20% relative risk reduction in incident atrial fibrillation, alongside reductions in mortality, myocardial infarction, and heart failure.
Limitations
- Retrospective observational design
- Need for randomized trials specifically designed to address AF-related outcomes
Key expert perspectives
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“From a clinical perspective, these findings support consideration of influenza vaccination as part of comprehensive cardiovascular and AFib prevention strategies in routine care. The absolute reduction in incident AFib observed in the present study was modest and, when considered in isolation, may appear limited at the individual level. However, influenza vaccination should not be viewed as a targeted intervention for AFib prevention alone, but rather as part of a broader cardiovascular prevention strategy. In this context, even modest relative risk reductions may translate into meaningful absolute benefits at the population level, given the high prevalence of AFib and the favorable safety of vaccination.”
Implication
Influenza vaccination was associated with lower incident AF risk; supports hypothesis generation but should not yet change practice.
Abstract
Background and Aims Influenza infection triggers cardiovascular events, and vaccination confers cardiovascular benefit in high-risk populations. Its role in preventing incident atrial fibrillation (AF) and cardiovascular outcomes in clinical practice remains uncertain. These associations were evaluated using a real-world target-trial emulation framework. Methods A retrospective cohort study was conducted using the TriNetX Global Collaborative Federated Research Data Network including adults with a routine healthcare visit in 2022. Influenza vaccination within the preceding year defined exposure; comparators had no recorded vaccination. A 1:1 propensity score matching across 65 baseline variables was applied. Outcomes included incident AF, cardiovascular events, and mortality, with subgroup analyses by age and baseline cardiovascular disease. Results After matching, 276 888 patients (138 444 per group) were included with excellent covariate balance. During a mean follow-up of 2.7 ± 0.7 years, influenza vaccination was associated with a significantly lower risk of incident AF [hazard ratio (HR) 0.80, 95% confidence interval (CI) 0.76–0.84; P < .0001]. The absolute annualized incidence of AF was 0.9% in vaccinated patients vs 1.1% in non-vaccinated patients. Vaccinated patients also had lower risks of all-cause mortality (HR 0.85, 95% CI 0.82–0.89), myocardial infarction (HR 0.91, 95% CI 0.86–0.97), incident heart failure (HR 0.92, 95% CI 0.88–0.96), and cardiovascular-related hospitalization (HR 0.97, 95% CI 0.95–0.99). Associations were directionally consistent across age and cardiovascular disease subgroups, without significant effect modification. Conclusions In a large retrospective observational real-world cohort, influenza vaccination was associated with lower risks of incident AF and multiple cardiovascular outcomes. These findings support vaccination as a potential upstream strategy for AF prevention and highlight the need for randomized trials specifically designed to address AF-related outcomes.
Coverage & sources
Journal, society, and media accounts. Useful signal, not independent expert judgment.
Discussion
No takes yet. Share an insight, caveat, or question.
Cite This Study
Fauchier et al. (2026) conducted a cohort in Adults with a routine healthcare visit (n=276,888). Influenza vaccination vs. No recorded vaccination was evaluated on Incident atrial fibrillation (HR 0.80, 95% CI 0.76-0.84, p=<0.0001). Influenza vaccination was associated with a significantly lower risk of incident atrial fibrillation compared to no vaccination (HR 0.80; 95% CI 0.76-0.84; P<0.0001).